Cellular therapies for lung disease: A distant horizon

Respirology

Volumn 16, Issue 2, 2011, Pages 223-237

  Moodley, Yuben ^a,b   Manuelpillai, Ursula ^c   Weiss, Daniel J ^d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

cell transplantation; cellular therapy; lung regeneration; stem cell

Indexed keywords

ALKALINE PHOSPHATASE; CLARA CELL PROTEIN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERLEUKIN 10; OCTAMER TRANSCRIPTION FACTOR 4; PROGRAMMED DEATH 1 LIGAND 1; PROSTAGLANDIN E2; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSFORMING GROWTH FACTOR BETA;

ACUTE LUNG INJURY; ARTICLE; ASTHMA; BIOETHICS; BONE MARROW CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LINEAGE; CELL MIGRATION; CELL SURVIVAL; CELL THERAPY; CELL TRANSDIFFERENTIATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; EMBRYONIC STEM CELL; ENDOGENOUS PROGENITOR CELL; ENDOTHELIAL PROGENITOR CELL; ENGRAFTMENT; GENETIC MANIPULATION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOGENICITY; LUNG ALVEOLUS CELL; LUNG CANCER; LUNG FIBROSIS; MESENCHYMAL STEM CELL; NONHUMAN; PATIENT SAFETY; PLACENTAL STEM CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; STEM CELL; TISSUE ENGINEERING; TISSUE PERFUSION;

ANIMALS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CLINICAL TRIALS AS TOPIC; GUIDED TISSUE REGENERATION; HUMANS; INFLAMMATION; LUNG; LUNG DISEASES; MICE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 79551564502     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2010.01914.x     Document Type: Article

References (138)

1. Warburton D, Lee MK,. Current concepts on lung development. Curr. Opin. Pediatr. 1999; 11: 188-92.
2. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004; 350: 2645-53.
3. Gross TJ, Hunninghake GW,. Idiopathic pulmonary fibrosis. N. Engl. J. Med. 2001; 345: 517-25.
4. Uhal BD, Joshi I, True AL, et al. Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro. Am. J. Physiol. 1995; 269: L819-28.
5. Uhal BD, Joshi I, Hughes WF, et al. Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am. J. Physiol. 1998; 275: L1192-1199.
6. Selman M, Pardo A,. Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc. Am. Thorac. Soc. 2006; 3: 364-72.
7. Myers JL, Selman M,. Respiratory epithelium in usual interstitial pneumonia/idiopathic pulmonary fibrosis: spark or destructive flame? Am. J. Respir. Crit. Care Med. 2004; 169: 3-5.
8. Bartram U, Speer CP,. The role of transforming growth factor beta in lung development and disease. Chest 2004; 125: 754-65.
9. Li CM, Khosla J, Hoyle P, et al. Transforming growth factor-beta(1) modifies fibroblast growth factor-2 production in type II cells. Chest 2001; 120: 60S-1S.
10. Pauwels R,. Global initiative for chronic obstructive lung diseases (GOLD): time to act. Eur. Respir. J. 2001; 18: 901-2.
11. Wang H, Liu X, Umino T, et al. Cigarette smoke inhibits human bronchial epithelial cell repair processes. Am. J. Respir. Cell. Mol. Biol. 2001; 25: 772-9.
12. Van Winkle LS, Evans MJ, Brown CD, et al. Prior exposure to aged and diluted sidestream cigarette smoke impairs bronchiolar injury and repair. Toxicol. Sci. 2001; 60: 152-64.
13. Hodge S, Hodge G, Holmes M, et al. Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur. Respir. J. 2005; 25: 447-54.
14. Aoshiba K, Nagai A,. Differences in airway remodeling between asthma and chronic obstructive pulmonary disease. Clin. Rev. Allergy Immunol. 2004; 27: 35-43.
15. Yokohori N, Aoshiba K, Nagai A,. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest 2004; 125: 626-32.
16. Liu Y, Gao W, Zhang D,. Effects of cigarette smoke extract on A549 cells and human lung fibroblasts treated with transforming growth factor-beta1 in a coculture system. Clin. Exp. Med. 2009.
17. Nyunoya T, Monick MM, Klingelhutz AL, et al. Cigarette smoke induces cellular senescence via Werner's syndrome protein down-regulation. Am. J. Respir. Crit. Care Med. 2009; 179: 279-87.
18. Hodge S, Hodge G, Scicchitano R, et al. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol. Cell. Biol. 2003; 81: 289-96.
19. Liu X, Engelhardt JF,. The glandular stem/progenitor cell niche in airway development and repair. Proc. Am. Thorac. Soc. 2008; 5: 682-8.
20. Watkins DN, Berman DM, Burkholder SG, et al. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003; 422: 313-17.
21. Duan D, Yue Y, Zhou W, et al. Submucosal gland development in the airway is controlled by lymphoid enhancer binding factor 1 (LEF1). Development 1999; 126: 4441-53.
22. Rock JR, Onaitis MW, Rawlins EL, et al. Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc. Natl. Acad. Sci. USA 2009; 106: 12771-5.
23. Evans MJ, Cabral-Anderson LJ, Freeman G,. Role of the Clara cell in renewal of the bronchiolar epithelium. Lab. Invest. 1978; 38: 648-53.
24. Hong KU, Reynolds SD, Giangreco A, et al. Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am. J. Respir. Cell. Mol. Biol. 2001; 24: 671-81.
25. Rawlins EL, Okubo T, Xue Y, et al. The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell. Stem. Cell. 2009; 4: 525-34.
26. Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005; 121: 823-35.
27. Deterding RR, Jacoby CR, Shannon JM,. Acidic fibroblast growth factor and keratinocyte growth factor stimulate fetal rat pulmonary epithelial growth. Am. J. Physiol. 1996; 271: L495-505.
28. Verghese GM, McCormick-Shannon K, Mason RJ, et al. Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury. Biologic and clinical significance. Am. J. Respir. Crit. Care Med. 1998; 158: 386-94.
29. Panos RJ, Bak PM, Simonet WS, et al. Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats. J. Clin. Invest. 1995; 96: 2026-33.
30. Liu XL, Sato S, Dai W, et al. The protective effect of hepatocyte growth-promoting factor (pHGF) against hydrogen peroxide-induced acute lung injury in rats. Med. Electron. Microsc. 2001; 34: 92-102.
31. Gonzalez RF, Allen L, Dobbs LG,. Rat alveolar type I cells proliferate, express OCT-4, and exhibit phenotypic plasticity in vitro. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009; 297: L1045-1055.
32. Uhal BD,. Cell cycle kinetics in the alveolar epithelium. Am. J. Physiol. 1997; 272: L1031-1045.
33. Weiss DJ, Kolls JK, Ortiz LA, et al. Stem cells and cell therapies in lung biology and lung diseases. Proc. Am. Thorac. Soc. 2008; 5: 637-67.
34. Serrano-Mollar A, Nacher M, Gay-Jordi G, et al. Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis. Am. J. Respir. Crit. Care Med. 2007; 176: 1261-8.
35. Germano D, Blyszczuk P, Valaperti A, et al. Prominin-1/CD133+ lung epithelial progenitors protect from bleomycin-induced pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2009; 179: 939-49.
36. Beckett T, Loi R, Prenovitz R, et al. Acute lung injury with endotoxin or NO2 does not enhance development of airway epithelium from bone marrow. Mol. Ther. 2005; 12: 680-86.
37. Bittmann I, Dose T, Baretton GB, et al. Cellular chimerism of the lung after transplantation. An interphase cytogenetic study. Am. J. Clin. Pathol. 2001; 115: 525-33.
38. Kleeberger W, Versmold A, Rothamel T, et al. Increased chimerism of bronchial and alveolar epithelium in human lung allografts undergoing chronic injury. Am. J. Pathol. 2003; 162: 1487-94.
39. Chang JC, Summer R, Sun X, et al. Evidence that bone marrow cells do not contribute to the alveolar epithelium. Am. J. Respir. Cell. Mol. Biol. 2005; 33: 335-42.
40. Swenson ES, Price JG, Brazelton T, et al. Limitations of green fluorescent protein as a cell lineage marker. Stem. Cells. 2007; 25: 2593-600.
41. Macpherson H, Keir P, Webb S, et al. Bone marrow-derived SP cells can contribute to the respiratory tract of mice in vivo. J. Cell. Sci. 2005; 118: 2441-50.
42. Loi R, Beckett T, Goncz KK, et al. Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells. Am. J. Respir. Crit. Care Med. 2006; 173: 171-9.
43. Spees JL, Pociask DA, Sullivan DE, et al. Engraftment of bone marrow progenitor cells in a rat model of asbestos-induced pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2007; 176: 385-94.
44. Levis J, Loi R, Butnor KJ, et al. Decreased asbestos-induced lung inflammation and fibrosis after radiation and bone marrow transplant. Am. J. Respir. Cell. Mol. Biol. 2008; 38: 16-25.
45. Bruscia EM, Ziegler EC, Price JE, et al. Engraftment of donor-derived epithelial cells in multiple organs following bone marrow transplantation into newborn mice. Stem Cells 2006; 24: 2299-308.
46. Harris RG, Herzog EL, Bruscia EM, et al. Lack of a fusion requirement for development of bone marrow-derived epithelia. Science 2004; 305: 90-93.
47. Herzog EL, Van Arnam J, Hu B, et al. Lung-specific nuclear reprogramming is accompanied by heterokaryon formation and Y chromosome loss following bone marrow transplantation and secondary inflammation. FASEB J. 2007; 21: 2592-601.
48. Aliotta JM, Sanchez-Guijo FM, Dooner GJ, et al. Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation. Stem Cells 2007; 25: 2245-56.
49. Wong AP, Keating A, Lu WY, et al. Identification of a bone marrow-derived epithelial-like population capable of repopulating injured mouse airway epithelium. J. Clin. Invest. 2009; 119: 336-48.
50. Hristov M, Erl W, Weber PC,. Endothelial progenitor cells: isolation and characterization. Trends. Cardiovasc. Med. 2003; 13: 201-6.
51. Yoon CH, Hur J, Park KW, et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005; 112: 1618-27.
52. Fadini GP, Schiavon M, Rea F, et al. Depletion of endothelial progenitor cells may link pulmonary fibrosis and pulmonary hypertension. Am. J. Respir. Crit. Care Med. 2007; 176: 724-5. author reply 725.
53. Fadini GP, Schiavon M, Cantini M, et al. Circulating progenitor cells are reduced in patients with severe lung disease. Stem Cells 2006; 24: 1806-13.
54. Pircher A, Kahler CM, Skvortsov S, et al. Increased numbers of endothelial progenitor cells in peripheral blood and tumor specimens in non-small cell lung cancer: a methodological challenge and an ongoing debate on the clinical relevance. Oncol. Rep. 2008; 19: 345-52.
55. Palange P, Testa U, Huertas A, et al. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. Eur. Respir. J. 2006; 27: 529-41.
56. Burnham EL, Taylor WR, Quyyumi AA, et al. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am. J. Respir. Crit. Care Med. 2005; 172: 854-60.
57. Asosingh K, Swaidani S, Aronica M, et al. Th1- and Th2-dependent endothelial progenitor cell recruitment and angiogenic switch in asthma. J. Immunol. 2007; 178: 6482-94.
58. Balasubramaniam V, Mervis CF, Maxey AM, et al. Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007; 292: L1073-1084.
59. Caplan AI,. Osteogenesis imperfecta, rehabilitation medicine, fundamental research and mesenchymal stem cells. Connect. Tissue Res. 1995; 31: S9-14.
60. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-17.
61. Iyer SS, Co C, Rojas M,. Mesenchymal stem cells and inflammatory lung diseases. Panminerva. Med. 2009; 51: 5-16.
62. Baber SR, Deng W, Master RG, et al. Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 2007; 292: H1120-28.
63. Xu J, Qu J, Cao L, et al. Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. J. Pathol. 2008; 214: 472-81.
64. Aslam M, Baveja R, Liang OD, et al. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am. J. Respir. Crit. Care Med. 2009; 180: 1122-30.
65. van Haaften T, Byrne R, Bonnet S, et al. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am. J. Respir. Crit. Care Med. 2009; 180: 1131-42.
66. Stagg J,. Immune regulation by mesenchymal stem cells: two sides to the coin. Tissue Antigens 2007; 69: 1-9.
67. Nasef A, Mathieu N, Chapel A, et al. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation 2007; 84: 231-7.
68. Rojas M, Xu J, Woods CR, et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am. J. Respir. Cell. Mol. Biol. 2005; 33: 145-52.
69. Xu J, Woods CR, Mora AL, et al. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007; 293: L131-141.
70. Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-43.
71. Kim WS, Park BS, Kim HK, et al. Evidence supporting antioxidant action of adipose-derived stem cells: protection of human dermal fibroblasts from oxidative stress. J. Dermatol. Sci. 2008; 49: 133-42.
72. Stolzing A, Scutt A,. Effect of reduced culture temperature on antioxidant defences of mesenchymal stem cells. Free. Radic. Biol. Med. 2006; 41: 326-38.
73. Spees JL, Olson SD, Ylostalo J, et al. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc. Natl. Acad. Sci. USA 2003; 100: 2397-402.
74. Wang G, Bunnell BA, Painter RG, et al. Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. Proc. Natl. Acad. Sci. USA 2005; 102: 186-91.
75. Ortiz LA, Dutreil M, Fattman C, et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc. Natl. Acad. Sci. USA 2007; 104: 11002-7.
76. Mei SH, McCarter SD, Deng Y, et al. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med. 2007; 4: e269.
77. Evans MJ, Kaufman MH,. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292: 154-6.
78. Reubinoff BE, Pera MF, Fong CY, et al. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 2000; 18: 399-404.
79. Amit M, Carpenter MK, Inokuma MS, et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 2000; 227: 271-8.
80. Brons IG, Smithers LE, Trotter MW, et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 2007; 448: 191-5.
81. Eswarakumar VP, Lax I, Schlessinger J,. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005; 16: 139-49.
82. Amit M, Shariki C, Margulets V, et al. Feeder layer- and serum-free culture of human embryonic stem cells. Biol. Reprod. 2004; 70: 837-45.
83. Bendall SC, Stewart MH, Menendez P, et al. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 2007; 448: 1015-21.
84. D'Amour KA, Agulnick AD, Eliazer S, et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 2005; 23: 1534-41.
85. Samadikuchaksaraei A, Cohen S, Isaac K, et al. Derivation of distal airway epithelium from human embryonic stem cells. Tissue Eng. 2006; 12: 867-75.
86. Wang D, Haviland DL, Burns AR, et al. A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 2007; 104: 4449-54.
87. Wang D, Morales JE, Calame DG, et al. Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Mol. Ther. 2010; 18: 625-34.
88. Takahashi K, Yamanaka S,. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-76.
89. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-72.
90. Lowry WE, Richter L, Yachechko R, et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. USA 2008; 105: 2883-8.
91. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917-20.
92. Okita K, Ichisaka T, Yamanaka S,. Generation of germline-competent induced pluripotent stem cells. Nature 2007; 448: 313-17.
93. Hanna J, Wernig M, Markoulaki S, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007; 318: 1920-23.
94. Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008; 321: 1218-21.
95. Mikkelsen TS, Hanna J, Zhang X, et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008; 454: 49-55.
96. Huangfu D, Osafune K, Maehr R, et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol. 2008; 26: 1269-75.
97. Somers A, Jean JC, Sommer CA, et al. Generation of transgene-free lung disease-specific human ips cells using a single excisable lentiviral Stem Cell Cassette. Stem Cells 2010; 28: 1728-40.
98. Ilancheran S, Moodley Y, Manuelpillai U,. Human fetal membranes: a source of stem cells for tissue regeneration and repair? Placenta 2009; 30: 2-10.
99. Sueblinvong V, Loi R, Eisenhauer PL, et al. Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells. Am. J. Respir. Crit. Care Med. 2008; 177: 701-11.
100. Moodley Y, Atienza D, Manuelpillai U, et al. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am. J. Pathol. 2009; 175: 303-13.
101. Miki T, Lehmann T, Cai H, et al. Stem cell characteristics of amniotic epithelial cells. Stem Cells 2005; 23: 1549-59.
102. Ilancheran S, Michalska A, Peh G, et al. Stem cells derived from human fetal membranes display multi-lineage differentiation potential. Biol. Reprod. 2007; 30: 2-10.
103. Cargnoni A, Gibelli L, Tosini A, et al. Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis. Cell Transplant. 2009; 18: 405-22.
104. Carraro G, Perin L, Sedrakyan S, et al. Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells 2008; 26: 2902-11.
105. Moodley Y, Ilancheran S, Samuel C, et al. Human Amnion Epithelial Cell Transplantation Abrogates Lung Fibrosis and Augments Repair. Am. J. Respir. Crit. Care Med. 2010; 182: 643-51.
106. Adachi Y, Oyaizu H, Taketani S, et al. Treatment and transfer of emphysema by a new bone marrow transplantation method from normal mice to Tsk mice and vice versa. Stem Cells 2006; 24: 2071-7.
107. Yuhgetsu H, Ohno Y, Funaguchi N, et al. Beneficial effects of autologous bone marrow mononuclear cell transplantation against elastase-induced emphysema in rabbits. Exp. Lung Res. 2006; 32: 413-26.
108. Ishizawa K, Kubo H, Yamada M, et al. Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema. FEBS. Lett. 2004; 556: 249-52.
109. Bruscia EM, Price JE, Cheng EC, et al. Assessment of cystic fibrosis transmembrane conductance regulator (CFTR) activity in CFTR-null mice after bone marrow transplantation. Proc. Natl. Acad. Sci. USA 2006; 103: 2965-70.
110. Bonfield TL, Koloze MF, Lennon DP, et al. Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010; 299: L760-70.
111. Nemeth K, Keane-Myers A, Brown JM, et al. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc. Natl. Acad. Sci. USA 2010; 107: 5652-7.
112. Manning E, Pham S, Li S, et al. Interleukin-10 delivery via mesenchymal stem cells: a novel gene therapy approach to prevent lung ischemia-reperfusion injury. Hum. Gene. Ther. 2010; 21: 713-27.
113. Lee JW, Fang X, Gupta N, et al. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc. Natl. Acad. Sci. USA 2009; 106: 16357-62.
114. Moodley Y, Ilancheran S, Samuel C, et al. Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair. Am. J. Respir. Crit. Care Med. 2010; 182: 643-51.
115. Umar S, de Visser YP, Steendijk P, et al. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension. Am. J. Physiol. Heart Circ. Physiol. 2009; 297: H1606-1616.
116. Kanki-Horimoto S, Horimoto H, Mieno S, et al. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension. Circulation 2006; 114: I181-185.
117. Studeny M, Marini FC, Dembinski JL, et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J. Natl. Cancer Inst. 2004; 96: 1593-603.
118. Moore BB, Hogaboam CM,. Murine models of pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008; 294: L152-160.
119. Gauldie J, Kolb M, Sime PJ,. A new direction in the pathogenesis of idiopathic pulmonary fibrosis? Respir. Res. 2002; 3: 1.
120. Cyranoski D,. Stem cells: 5 things to know before jumping on the iPS bandwagon. Nature 2008; 452: 406-8.
121. Yan X, Liu Y, Han Q, et al. Injured microenvironment directly guides the differentiation of engrafted Flk-1(+) mesenchymal stem cell in lung. Exp. Hematol. 2007; 35: 1466-75.
122. Salazar KD, Lankford SM, Brody AR,. Mesenchymal stem cells produce Wnt isoforms and TGF-beta1 that mediate proliferation and procollagen expression by lung fibroblasts. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009; 297: L1002-1011.
123. Wang XX, Zhang FR, Shang YP, et al. Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J. Am. Coll. Cardiol. 2007; 49: 1566-71.
124. Aguilar S, Nye E, Chan J, et al. Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung. Stem Cells 2007; 25: 1586-94.
125. Rubio D, Garcia S, Paz MF, et al. Molecular characterization of spontaneous mesenchymal stem cell transformation. PLoS One 2008; 3: e1398.
126. Houghton J, Stoicov C, Nomura S, et al. Gastric cancer originating from bone marrow-derived cells. Science 2004; 306: 1568-71.
127. Cogle CR, Theise ND, Fu D, et al. Bone marrow contributes to epithelial cancers in mice and humans as developmental mimicry. Stem Cells 2007; 25: 1881-7.
128. Xin H, Sun R, Kanehira M, et al. Intratracheal delivery of CX3CL1-expressing mesenchymal stem cells to multiple lung tumors. Mol. Med. 2009; 15: 321-7.
129. Loebinger MR, Eddaoudi A, Davies D, et al. Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Res. 2009; 69: 4134-42.
130. Duinsbergen D, Salvatori D, Eriksson M, et al. Tumors originating from induced pluripotent stem cells and methods for their prevention. Ann. N. Y. Acad. Sci. 2009; 1176: 197-204.
131. Nichols JE, Cortiella J,. Engineering of a complex organ: progress toward development of a tissue-engineered lung. Proc. Am. Thorac. Soc. 2008; 5: 723-30.
132. Sugihara H, Toda S, Miyabara S, et al. Reconstruction of alveolus-like structure from alveolar type II epithelial cells in three-dimensional collagen gel matrix culture. Am. J. Pathol. 1993; 142: 783-92.
133. Mondrinos MJ, Koutzaki S, Jiwanmall E, et al. Engineering three-dimensional pulmonary tissue constructs. Tissue Eng. 2006; 12: 717-28.
134. Blau H, Guzowski DE, Siddiqi ZA, et al. Fetal type 2 pneumocytes form alveolar-like structures and maintain long-term differentiation on extracellular matrix. J. Cell. Physiol. 1988; 136: 203-14.
135. Andrade CF, Wong AP, Waddell TK, et al. Cell-based tissue engineering for lung regeneration. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007; 292: L510-18.
136. Cortiella J, Nichols JE, Kojima K, et al. Tissue-engineered lung: an in vivo and in vitro comparison of polyglycolic acid and pluronic F-127 hydrogel/somatic lung progenitor cell constructs to support tissue growth. Tissue Eng. 2006; 12: 1213-25.
137. Ott HC, Clippinger B, Conrad C, et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat. Med. 2010; 16: 927-33.
138. Zhu JH, Wang XX, Zhang FR, et al. Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: open-label pilot study. Pediatr. Transplant. 2008; 12: 650-55.